Arno Therapeutics, Inc.
OTC: ARNI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David M. Tanen
- Employees
- 4
- Headquarters
- Flemington, United States
- IPO year
- 2008
- Market cap
- $4.9K
- Website
- https://www.arnothera.com
Loading ARNI…
Loading profile data…Frequently asked questions about ARNI
What does Arno Therapeutics, Inc. (ARNI) do?
Arno Therapeutics, Inc., headquartered in Flemington, New Jersey, operates as a biopharmaceutical enterprise focused on discovering and advancing treatments for cancer and other severe health conditions. The company's developmental portfolio includes several key compounds: Onapristone, a type 1 anti-progestin hormone blocker, is currently underg...
Where does ARNI trade?
Arno Therapeutics, Inc. (ARNI) trades on the Other OTC.
What sector is ARNI in?
Arno Therapeutics, Inc. (ARNI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Arno Therapeutics, Inc.?
David M. Tanen is the chief executive officer of Arno Therapeutics, Inc. (ARNI).
Where is Arno Therapeutics, Inc. headquartered?
Arno Therapeutics, Inc. is headquartered in United States.
Does ARNI pay a dividend?
Arno Therapeutics, Inc. (ARNI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ARNI go public?
Arno Therapeutics, Inc. (ARNI) completed its initial public offering in 2008.